large-scale randomized controlled trials of Epithalon have not been published
Levtchenko EN, van Dael CM, de Graaf-Hess AC, Wilmer MJ, van den Heuvel LP, Monnens LA, Blom HJ (2006) Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis
Avoid in pregnant or breastfeeding individuals due to a lack of appropriate data
Gray area exists but clinics operating this way haven't faced legal action
FDA Status Most peptides used therapeutically are obtained through FDA-registered compounding pharmacies
Up to 10% of patients with acute cholecystitis do not have gallstones [145] and can develop acute acalculous cholecystitis with increased morbidity and mortality rates compared to calculous cholecystitis [92, 146,147,148,149,150,151]